Strides gets USFDA approval for butalbital, acetaminophen and caffeine tablets
They are indicated for the relief of the symptom complex of tension or muscle contraction headache
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Strides Pharma Science
Browsing Tag
Strides Pharma Science
Strides gets USFDA approval for Ursodiol tablets
Product to be launched immediately and marketed by Strides Pharma in the US market
UK MHRA inspection of Strides facility at Puducherry concludes successfully
The company receives renewed GMP status for the facility from UK MHRA
SeQuent Scientific to sell stake in Strides Pharma
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573…
Strides Pharma to conduct trials in India for potential COVID-19 drug
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of…
Strides develops and commences export of Favipiravir Antiviral Tablets
The product is currently being exported to GCC countries to treat patients under their treatment program for COVID-19
Strides announces successful completion of US FDA inspection conducted at Bangalore facility
Inspection conducted in January 2020 was for specific Extended Release applications
Strides receives US FDA approval for Tetracycline Hydrochloride Capsules
The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc (previously Heritage…
Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International
Of the 18 products successfully developed by Pii with their Pharmaceutics know-how, 11 are currently approved by US FDA while the…
Strides posts consolidated revenue at ₹7,353 m in Q3FY20
Consolidated EBITDA was at ₹1,851 million
Strides Pharma Science has announced its Q3FY20 results. In Q3FY20, the consolidated…
